NIH-funded research R01 grant

Controlling brain cell activity to reduce seizures and improve memory in epilepsy

Official title: Closed-loop Control of Interneuron Spike Timing in Epilepsy

Funded at Icahn School of Medicine at Mount Sinai · NIH-11232536 · Data updated 2026-11-12

This study is looking at how adjusting certain brain cells can help reduce seizures and improve memory in people with epilepsy, using a special technique in rodent models to see if changing how these cells work can make a difference.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2025
Project endFebruary 28, 2027
Funding year2025
Award (this year)$22,558
NIH project number3R01NS136590-01S1
Project IDNIH-11232536 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with temporal lobe epilepsy who experience frequent seizures and cognitive impairments.

Less likely to help

Patients with epilepsy who do not have cognitive deficits or those with other types of epilepsy may not benefit from this research.

What this research studies

This research investigates how controlling the timing of specific brain cells, called interneurons, can affect seizures and cognitive function in epilepsy. Using a novel closed-loop optogenetic system, the researchers aim to manipulate the activity of these interneurons in rodent models of temporal lobe epilepsy. By adjusting their firing patterns, the study seeks to determine if this can decrease seizure frequency and enhance memory performance. The findings could provide insights into the relationship between brain synchronization and cognitive deficits associated with epilepsy.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that reduce seizures and improve cognitive function for patients with epilepsy.

How similar studies have gone: Previous research has shown promise in using optogenetic techniques to manipulate brain activity, suggesting potential success for this novel approach.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Shuman, Tristan — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Shuman, Tristan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.